News

Report
Our 2025 sustainability year in review: the highlights

Our 2025 sustainability year in review: the highlights

Our 2025 sustainability year in review shows major progress: −17% emissions, 99% renewable electricity, SBTi‑validated targets, and stronger ESG ratings.
May 13, 2026
TFS expert Mesfin James highlights Europe’s clinical development strengths and regulatory shifts creating new sponsor opportunities.
Europe’s clinical development landscape: does the EU hold a busted flush or a full house?

Europe’s clinical development landscape: does the EU hold a busted flush or a full house?

TFS expert Mesfin James highlights Europe’s clinical development strengths and regulatory shifts creating new sponsor opportunities.
May 6, 2026
PR image
TFS HealthScience Recognized with B Score in 2025 CDP Climate Change Assessment

TFS HealthScience Recognized with B Score in 2025 CDP Climate Change Assessment

TFS HealthScience achieves a B score in the 2025 CDP Climate Change assessment, demonstrating strengthened climate governance and responsible CRO practices.
February 8, 2026
image
Expanding the Frontiers of Neuroscience: TFS Strengthens Its Gene Therapy Portfolio in Neurodegenerative Diseases

Expanding the Frontiers of Neuroscience: TFS Strengthens Its Gene Therapy Portfolio in Neurodegenerative Diseases

TFS expands its global neuroscience portfolio, strengthening its gene therapy expertise across neurodegenerative diseases through innovation & collaboration.
November 17, 2025
TFS HealthScience achieves SBTi validation for its science-based climate targets, marking a major milestone toward a net-zero future.
TFS HealthScience Secures SBTi Validation, Advancing Its Commitment to a Net-Zero Future

TFS HealthScience Secures SBTi Validation, Advancing Its Commitment to a Net-Zero Future

TFS HealthScience has received validation from the Science Based Targets initiative (SBTi) for its near-term and net-zero greenhouse gas reduction goals, underscoring its commitment to science-based decarbonization and a healthier,…
October 23, 2025
TFS HealthScience Strengthens Global Ophthalmology Unit with Strategic Hires and Integrated Delivery Model
TFS HealthScience Strengthens Global Ophthalmology Unit with Strategic Hires and Integrated Delivery Model

TFS HealthScience Strengthens Global Ophthalmology Unit with Strategic Hires and Integrated Delivery Model

TFS HealthScience, a leading global Contract Research Organization, is expanding its ophthalmology business unit with new leadership talent and enhanced delivery capabilities to meet rising demand for specialized clinical trial…
July 16, 2025
markus granlund named permanent ceo of tfs healthscience
Markus Granlund Permanent CEO of TFS HealthScience

Markus Granlund Permanent CEO of TFS HealthScience

Markus Granlund, who has been serving as Interim CEO of TFS HealthScience since February 2025, has officially been appointed as the company’s Chief Executive Officer, effective immediately.
June 25, 2025